| Stage | CDW | % of rev | CSCO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.8B | 100.00% | $17.3B | 100.00% | CSCO ×2.55 |
| Gross profit | $1.4B | 20.51% | $11.1B | 64.13% | CSCO +43.6pp |
| Operating income | $490M | 7.25% | $4.3B | 24.72% | CSCO +17.5pp |
| Pre-tax income | $424M | 6.28% | $4.9B | 28.59% | CSCO +22.3pp |
| Net income | $310M | 4.59% | $3.9B | 22.37% | CSCO +17.8pp |
| Stage | CDW | CSCO | Gap · A − B |
|---|---|---|---|
| Revenue | $6.8B100.00% | $17.3B100.00% | CSCO ×2.55 |
| Gross profit | 20.51%$1.4B | 64.13%$11.1B | CSCO +43.6pp |
| Operating income | 7.25%$490M | 24.72%$4.3B | CSCO +17.5pp |
| Pre-tax income | 6.28%$424M | 28.59%$4.9B | CSCO +22.3pp |
| Net income |
| 4.59%$310M |
| 22.37%$3.9B |
| CSCO +17.8pp |